Tel Aviv University

Hoth Licenses VCU Research On Halting Spike Protein Binding Hoth Therapeutics Inc. announced on 20 May that it is licensing technology and related intellectual property developed at Virginia Common

GE Healthcare and Vanderbilt University Medical Center are working together to combine immuno-oncology with precision medicine through a five-year collaboration unveiled Jan. 6, to determine which

While the traditional summer recess led to an expected drop in the number of alliances in August, there was still a good level of activity from medtech players – with a couple of joint ventures thrown

Alcresta Inc. Alcresta brings in $49.4m via Series C Alcresta Inc. (therapies for gastrointestinal disorders and rare diseases) raised $49.4m in its Series C financing to new backer Athyrium a